Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Stage Four Melanoma Patient Grateful to Hadassah for Personally Tailored Clinical Trial Which Has Offered Him “A Chance to Fight”

Stewart and Maggie Greenberg

After being told there was no treatment that could save him, a Florida attorney with stage four melanoma received a new lease on life when he was accepted into a personally tailored melanoma vaccine clinical trial at the Hadassah Medical Center.

Stewart Greenberg and his wife, Maggie, had decided to go on a Miami Jewish Federation mission to Israel, together with other members of their synagogue. Shortly afterward, he was diagnosed with stage four melanoma. Facing a devastating risk of metastasis, Stewart consulted various physicians, but they were unable to offer him any strategic plan to combat this grave prognosis--including those at the United States National Institutes of Health.

Hadassah Life Member Caryn Montague, who was helping him with his disability insurance, asked Stewart if he would like her to try to get him an appointment at the Hadassah Medical Center to meet with a melanoma specialist while he was in Jerusalem on the mission. Stewart received an appointment with Dr. Michal Lotem, head of the Center for Melanoma and Cancer Immunotherapy at Hadassah's Sharett Institute of Oncology.

"You just felt good meeting her," Stewart relates. Dr. Lotem has been conducting clinical trials with a personalized melanoma vaccine for 10 years. "As far as I know," Stewart says, "this particular clinical trial is not being conducted anywhere else—and I have done a lot of research."

The treatment process involves taking tissue from the melanoma patient or as in Stewart's case, matching the patient's tissue type and using donors' melanoma lines to create more cells, which are then irradiated and injected into the patient. The cells work like a vaccine, triggering the patient's immune system.

Stewart and Maggie, a Hadassah life member, moved to Jerusalem for 99 days." Maggie has been there and done everything with me," Stewart relates. "We went on the mission together. She and I went to the hospital together. We are a team. Every cancer patient should be as lucky as I am to have such a fantastic partner and support. Without her love, encouragement, and support, I would not have been able to take this journey. She is my rock and my angel."

Stewart's treatment involved 21 injections of the vaccine over a 90-day period. "Hadassah is an incredible place," he says--"caring, sweet, loving, with such respect for the patients." During that time, he relates, he not only received terrific care, but he and Maggie also made great friends, were invited to celebrate many family occasions with those they met, as well as being given the opportunity to attend a swearing-in ceremony for Israeli paratroopers.

As an attorney who specializes in medical malpractice, Stewart has interacted with many doctors. "Never," he says, "have I met doctors like Prof. Lotem." At midnight, he relates, she was answering his e-mails. While he was at the hospital, he witnessed her taking calls from all around the world regarding patients she has treated. Dr. Lotem is now looking toward additional research on a "second-generation" melanoma vaccine.

"When people think of Israel," Stewart notes, "they think of sand and soldiers; camels and war. I would like them to know about the biomedical achievements and how Israel contributes to the health of our world." He brings out, too, that relations between Israel and countries where there is no relationship are built because people from those countries receive quality care at Hadassah.

Before his illness, Stewart knew little about Hadassah and was unaware of the breadth of its impact. He has shared his story with the members of several Hadassah chapters in Florida and does so with great enthusiasm.

Stewart will be returning to Hadassah for a booster treatment in March. "Prof. Lotem," he says, "has given me a chance to fight."

For more stories from Hadassah Medical Organization, click here>>

Date: 1/25/2013


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America